Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (CSE: $CRFT.C) (CSE: $BLO.C) (TSXV: $KHRN.V) (OTC: $SKDI)
Delta, Kelowna, BC, November 18th, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast
edition of cannabis news and
stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/11181CRFT-BLO-KHRN-SKDI.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few early announcements.
Pasha
Brands Ltd. (CSE: CRFT) (OTC: CRFTF), Canada's largest craft cannabis brand
house, last month called for the complete expungements of cannabis records, and
a review of post-legalization enforcement. In the wake of raids on the nation's
oldest compassion clubs and dispensaries, Pasha is now calling on the federal government to look into new models of medical access.
As legal adult-use
is clearly failing to meet the needs of the same cannabis patients being left
behind by the medical access program, and as an association of legal cannabis
producers calls on the federal government to increase enforcement on brick and
mortar and online illicit retailers, Pasha calls on the federal government to
instead exempt Canada's earliest medical dispensaries, it's patients, and it's
producers from the Cannabis Act, and to conduct a review of the current medical
framework.
Several court cases
have set precedents in Canada that have been largely ignored by successive
governments. The right to access medical cannabis has been well-established by
the courts, but this access is lacking.
Not all patients who require cannabinoid-based medicine have access to
online sales, fixed addresses, credit cards, or the funds required to purchase
their medicine. For these reasons and others, the recommendations following
both R. v. Smith and Allard v. Canada touted the benefits of storefront access
at dispensaries and compassion clubs.
What's more, access
to medical cannabis is protected under Section 7 of the Charter of Rights and
Freedoms. This access is also meant to include 'protection from delay'. The
2002 Report of the Senate Special Committee on Illegal Drugs found that medical
dispensary practices were in line with therapeutic indications, and that moving
forward, Health Canada should work with compassion clubs, rather than against
them. By the Senate's own recommendations, these outlets should be part of Canada's
existing medical cannabis framework.
Pasha supports this
petition calling on the federal government to take action on these now
17-year-old recommendations by supporting and encouraging the development of
new models of access; to undertake a full review of the current state of
medical cannabis access while including the organizations that inspired and
impressed the Senate Committee in 2002; and to grant exemptions to medicinal
dispensaries, their patients, and suppliers as the review is ongoing.
Pasha has focused
on getting existing farmers into the legal adult-use market, but recognizes the
need for improved medical access. "The pre- and post-legalization gold
rush on both licit, and illicit, sides of the industry has skewed our
understanding of what it means to safely access cannabis," says Jamie
Shaw, Pasha's Chief Communications and Culture Officer. "The current
framework fails patients, and without proper medical access, they are forced to
purchase their medicine from the illicit market or go without. We hope that by
gaining MP support for this petition, the public will get a chance to remind
the federal government that it was medical patients that carved the path that
we're on today, and it is they who still bear the brunt of bad policy."
The petition
(e-2301) can be read here: https://www.pashabrands.com/petition-to-the-government-of-ca/
Cannabix
Technologies Inc. (CSE: BLO) (OTC: BLOZF) developer of marijuana breathalyzer
devices for law enforcement and the workplace, reports that engineers have completed
assembly of a handheld portable version of the (UBC) THC Breath Analyzer and
are preparing the device to build upon promising human tests conducted earlier
this year in Kelowna, BC. Over the last
several weeks, Company engineers have reduced the size of several components
inside the THCBA for a compact handheld device.
Cannabix has been conducting extensive lab testing with the new device.
The THC Breath Analyzer (“THCBA”) incorporates sensitive microfluidic sensor
technology for the detection of ∆9-tetrahydrocannabinol (“THC”) from breath.
Furthermore, several software upgrades are being completed to use cloud-based
machine learning (ML) techniques to process data more quickly. Initial ML analysis
will be performed by experts at UBC. Cannabix is commissioning several
additional units in the short term and expects that these devices will be
available for broader multi site testing this winter. The Company has made the
first pictures of the newly built THCBA available on its website at
cannabixtechnologies.com.
Dr. Mina Hoorfar
stated, “We have been working hard in collaboration with Cannabix to optimize
the device and its components. Our
mutual goal continues to be developing an affordable, portable, fast and
accurate device for use with a range of potential users.”
Rav Mlait, CEO,
stated, “Our team has been working intensely on our devices for the law
enforcement and workplace markets. Several additional police, private and
government related agencies have been in touch with Cannabix this fall, showing
interest in piloting our devices, as marijuana use for recreational and medical
purposes is expanding across various jurisdictions in the United States and we
have surpassed one year of recreational use across Canada. Furthermore, we are
seeing police and others becoming more open to new technologies related to
cannabis impairment detection. We are very excited for the additional prospects
for the THCBA because of its single stage, direct breath capability, compact
portable design and ability to provide results quickly.”
The Company reports
that it has improved several components within its FAIMS (field asymmetric
waveform ion mobility spectrometry) THC detection device. More recently,
engineers have enhanced sample flow conditions within the unit, worked
intensely on ion optics and are testing a new multi-plate detector unit. The
Company is also pleased to report that it has been testing with both direct
breath and breath collection methods using the FAIMS system.
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) announced the official launch of the Company's
Kuida brand in the United States. Beginning this Wednesday, November 20,
Kuida's line of CBD skincare products will become available for purchase to US
consumers at retail, initially in Los Angeles, before a planned expansion in
priority US states where sale of hemp-derived CBD is permitted.
In the California
market, Kuida will initially be distributed and sold through a partnership with
leading lifestyle media and retail brand, Cannabis Now. With a prime flagship
location in Los Angeles and an expanding retail network including three planned
stores across major US cities, Cannabis Now offers a selection of non-THC
health and wellness products in an experiential retail environment designed to
educate both experienced and new cannabis consumers. Through an exclusive
activation at Cannabis Now's high-traffic Beverly Hills location, the Kuida
brand will target an affluent, on-trend audience of beauty and cannabis
consumers, influencers, and professionals across Los Angeles as well as the
wider US market.
"We are
incredibly proud to be the first Colombian brand to introduce legal CBD
products in the US market," stated Elsa Navarro, Skin Unit Director of
Khiron Life Sciences. "As we enter the United States market and commence
sales, we bring proven success in brand building, a scientifically-backed, GMP
lab made product, and a powerful branding and marketing campaign that resonates
with consumers. As a result, we find ourselves in a strong position to reach
consumers and gain market share in the fast-growing US skincare market."
Eugenio Garcia, CEO
and Founder at Cannabis Now comments: "At Cannabis Now, we are disrupting
the cannabis retail space to introduce first-of-its-kind experiential and
education-focused experiences. Khiron shares our commitment to innovation and
high-quality products that help improve the consumer experience, and Kuida is
an ideal addition to our retail marketplace. We are very excited to share Kuida
with our customer base and wide following in the US."
In addition to
in-store programming, the Company will also support the retail pop-up and drive
sales through a comprehensive marketing campaign spanning mass media,
experiential activations, social media, and influencer partnerships. Kuida will
further collaborate with Cannabis Now on educational content as well as print
and digital advertising, leveraging the brand's media offering to reach its
following of 4.2 million US consumers.
The introduction of
Kuida in the United States will kick off with a launch event on Wednesday,
November 20th at Cannabis Now with the Khiron executive team, beauty
experts and lifestyle influencers. Investors are invited to experience Kuida
for themselves and to join Khiron Life Sciences as they celebrate this
momentous milestone!
Sun
Kissed Industries Inc. (OTC:SKDI), an emerging player in the CBD
marketplace, announced that its soon-to-be subsidiary, Hakuna
Supply/Products Group, Inc., an award-winning CBD-based products company, is
releasing for sale its new “Fingerprint Lock Box” biometric sensing storage
device for cannabis, hemp, and CBD products in time for the 2019 Holiday
Shopping Season.
Sun Kissed and
Hakuna are nearing the signing of their Definitive Agreement, by which Sun
Kissed will acquire 100% of the issued and outstanding shares of Hakuna, a
private CBD products leader booking strong revenues with over 110 established
retail distribution partners across more than 20 states in the domestic US
market.
“I’m truly excited
that the Hakuna acquisition appears set to be finalized sooner than expected as
Hakuna continues to roll out powerful new products,” stated Carl Grant, CEO of
Sun Kissed. “As we get ready to close the acquisition, our attention will
quickly turn toward marketing the many award-winning top-tier products Hakuna
has crafted, with this beautiful new state-of-the-art biometric sensing
Fingerprint Lock Box representing yet another success story as shoppers get set
for the Holiday Season.”
Management notes
that the new Hakuna Fingerprint Lock Box sits at the intersection of major
market trends, with the biometric sensing market already projected to grow from
$3.5 billion in 2019 to $7.1 billion by 2024 at a CAGR of 15.3%, according to
recent research from MarketsandMarkets, and overall sales within the legalized
U.S. cannabis industry expected to reach $13.6 billion throughout 2019, for a
32% increase over 2018, according to New Frontier data.
The Fingerprint
Lock Box is a perfect holiday gift idea, with a sleek and stylish look, and a
robust design built to keep products safe and secure behind a lock controlled
through a fingerprint-triggered biometric sensing mechanism, with an included
back-up metal key for extra assurance. The box can be charged by a
USB-compatible, portable, removable wireless charger located at its base.
“We are working
closely with Hakuna to provide for a smooth transition as we get set to
integrate Hakuna’s operations and prepare to invest in growing the company into
one of the biggest CBD players in the US domestic market,” continued Mr. Grant.
“That shouldn’t be a stretch given the company’s massive existing distribution
footprint and its award-winning product line. We look forward to updating
current and prospective shareholders as events transpire.”
Investor ideas reminds all listeners to read our
disclaimers and disclosures on the
Investorideas.com website and this podcast is not an
endorsement to buy products or services or securities. Investors are reminded
all investment involves risk and possible loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com Global investors
must adhere to regulations of each country. Please read Investorideas.com
privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis
except where permissible by law. Our site does not possess, distribute, or sell
cannabis products.
Follow
us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment